1,374 results
P
elderly individuals
I/C
sufficient dietary intake of vitamin K, insufficient dietary intake of vitamin K
O
risk of osteoarthritis (OA) and pathological joint features
P
patients with non-valvular atrial fibrillation (NVAF)
I/C
non-vitamin K antagonist oral anticoagulants (NOACs), vitamin K antagonists (VKAs)
O
left atrial thrombus (LAT) formation before cardioversion or catheter ablation
P
patients with deep vein thrombosis and/or pulmonary embolism
I/C
rivaroxaban and apixaban, standard of care (SoC)
O
reduced risks of recurrent VTE, lower rate of major bleeding events, all-cause death
P
traumatic lower extremity artery injury
I/C
endovascular therapy (ET), open surgical repair (OSR), endovascular therapy (ET), open surgical repair (OSR)
O
amputation, fasciotomy or compartment syndrome, mortality, length of stay, lower extremity nerve injury
P
patients with ankle instability (AI)
I/C
case-control study, Patients with AI had a lower activation of peroneal muscles before landing
O
muscle activation of the lower extremity before landing
P
51956 participants
I/C
7 different statins (simvastatin, fluvastatin, atorvastatin, rosuvastatin, lovastatin, pravastatin, and pitavastatin), comparing the lipid-lowering efficacy of no less than two of the included statins (or statin vs. placebo)
O
LDL-C lowering
P
28 studies with 266,227 cases of lower limb OA
I/C
physically demanding occupations or occupational tasks, lifting heavy loads (>10 kg/week), squatting/kneeling, standing (>2 h/daily), walking
O
development of lower limb osteoarthritis (OA)
P
Vitamin K antagonist (VKA) reversal
I/C
Four-factor prothrombin complex concentrate (4F-PCC), Weight-based dose (WB)
O
Goal INR
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
children and adolescents with PTSD
I/C
psychological interventions, waitlist, active control conditions
O
effect size